Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis

Vaccine

Volumn 16, Issue 8, 1998, Pages 761-767

  Reddin, Karen M ^a   Easterbrook, Timothy J ^a   Eley, Stephen M ^b   Russell, Paul ^b   Mobsby, Vivien A ^a   Jones, David H ^a   Farrar, Graham H ^a   Williamson, E Diane ^b   Robinson, Andrew ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

F1 antigen delivery; Liposome; PLG microspheres; Vaccination; Yersinia pestis

Indexed keywords

ALUMINUM HYDROXIDE; ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; LIPOSOME; MICROSPHERE; POLYGLACTIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; VACCINATION; YERSINIA PESTIS;

EID: 0032077280     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00305-8     Document Type: Article

References (31)

1. 1 Meyer, K.F. Effectiveness of live or killed plague vaccines in man. Bull WHO 1970, 42, 653-666.
2. 2 Bartelloni, P.J., Marshall, J.D. and Cavanaugh, D.C. Clinical and serological responses to plague vaccine. U.S.P. Milit. Med. 1973, 138, 720-722.
3. 3 Williams, J.E., Altieri, P.L., Berman, S., Lowenthal, P.J. and Cavanaugh, D.C. Potency of killed plague vaccine prepared from avirulent Yersinia pestis. Bull. WHO. 1980, 58, 753-756.
4. 4 Reisman, R.E. Allergic reactions due to plague vaccine. J. Allergy 1970, 46, 49-55.
5. 5 Marshall, J.D., Bartelloni, P.J., Cavanaugh, D.C., Kadull, P.J. and Meyer, K.F. Plague immunisation II. Relation of adverse clinical reactions to multiple immunisations with killed vaccine. J. Inf. Dis. 1974, 129, S19-25.
6. 6 Meyer, K.F., Cavanaugh, D.C., Bartelloni, P.J. and Marshall, J.D. Plague immunisation. I. Past and present trends. J. Inf. Dis. 1974, 129, S30-36.
7. 7 Brubaker, R.R. Factors promoting acute and chronic diseases caused by Yersiniae. Clin. Micro. Rev. 1991, 4, 309-324.
8. 8 Straley, S.C. and Perry, R.D. Environmental modulation of gene expression and pathogenests in Yersinia. Trends. Microbioi. 1996, 3, 310-317.
9. 9 Rust, J.H., Cavanaugh, D.C., O'Shita, R. and Marshall, J.D. The role of domestic animals in the epidemiology of plague I. Experimental infection of dogs and cats. J. Inf. Dis. 1971, 124, 522-526.
10. 10 Simpson, W.J., Thomas, T.G. and Schwan, T.G. Recombinant capsular antigen (Fraction 1) from Yersinia pestis induces a protective antibody response in Balb/c mice. Am. J. Trop. Med. Hyg. 1990, 43, 389-396.
11. 11 Shepherd, A.J., Hummitzsch, D.E., Lemon, P.A., Swanepoel, R. and Searle, L.A. Comparative tests for detection of plague antigen and antibody in experimentally infected wild rodents. J. Clin. Microbiol. 1986, 24, 1075-1078.
12. 12 Williams, J.E., Arntzen, L., Tyndal, G.L. and Isaacson, M. Application of enzyme irnmunoassays for the confirmation of clinically suspect plague in Namibia. Bull. WHO. 1982, 64, 745-752.
13. 13 Galyov, E.E., Smirnov, O.Y. and Karlishev, A.V. et al. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. FEBS Lett. 1990, 277, 230-232.
14. 14 Baker, E.E., Sommer, H., Meyer, E. and Meyer, K.F. Studies on immunisation against plague. I. The isolation and characterisation of the soluble antigen of Pasteurella pestis. J. Immunol. 1952, 68, 131-145.
15. 15 Rodrigues, C.G., Carneiro, C.M.M., Barbosa, C.F.T. and Nogueira, R.A. Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes. Braz. J. Med. Biol. Res. 1992, 25, 75-79.
16. 16 Williamson, E.D., Eley, S.M. and Griffin, K.F. et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 1995, 12, 223-230.
17. 17 Jones, D.H., McBride, B.W., Jeffrey, H. and O'Hagan, D.T. et al. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbrae. Vaccine 1995, 13, 675-681.
18. 18 Cahill, E.S., O'Hagan, D.T. and Illum, L. et al. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microspheres. Vaccine 1995, 13, 455-462.
19. 19 Eldridge, J.H., Staas, J.K., Chen, D., Marx, P.A., Tice, T.R. and Gilley, R.M. New advances in vaccine delivery systems. Sem. Hematol. 1993, 30, 16-24.
20. 20 Eldridge, J.H., Staas, J.K. and Meulbrook, J.A. Biodegradable and biocompatible poly (DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralising antibodies. Inf. Imm. 1991, 59, 2978-2986.
21. 21 Gregoriadis, G. and Panagiotidi, C. Immunoadjuvant action of liposomes: comparison with other adjuvants. Immunol. Lett. 1989, 20, 237-240.
22. 22 Aramaki, Y., Fujii, Y., Yachi, K., Kikuchi, H. and Tsuchiya, S. Activation of systemic and mucosal immune response following nasal administration of liposomes. Vaccine 1994, 12, 1241-1244.
23. 23 Mestecky, J., Moldoveanu, Z., Novak, M. and Compans, R.W. Mucosal immunity and strategies for novel microbial vaccines. Acta. Paediatr. Japan 1994, 36, 537-544.
24. 24 Ben-Ahmeida, E.T., Gregoriadis, G., Potter, C.W. and Jennings, R. Immunopotentiation of local and systemic humoral responses by ISCOMS, liposomes and FCA: role in protection against influenza A in mice. Vaccine 1993, 11, 1302-1309.
25. 25 deHaan, A., Tomee, J.F.C., Huchshom, J.P. and Wilschut, J. Liposomes as immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. Vaccine 1995, 13, 1320-1324.
26. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Inf. Imm. 1986, 51, 445-454.
27. 27 O'Hagan, D.T., McGee, J.P. and Holmgren, J. et al. Biodegradable microspheres for oral immunisation. Vaccine 1993, 11, 149-154.
28. 28 Jones, D.H., McBride, B.W., Tnornton, C., O'Hagan, D.T., Robinson, A. and Farrar, G.H. Orally administered microencapsulated Bordetella pertussis fimbrae protect mice from B. pertussis respiratory infection. Inf. Imm. 1996, 64, 489-494.
29. 29 Gregoriadis, G. Overview of liposomes. J. Antimicrob. Chemother. 1991, 28, 39-48.
30. 30 Russell, P., Eley, S.M., Hibbs, S.E., Manchee, R.J., Staggs, A.J. and Titball, R.W. A comparison of piague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995, 13, 1551-1556.
31. 31 Cohen, S., Alonso, M.J. and Langer, R. Novel approaches to controlled-release antigen delivery. Int. J. Tech. Assess. 1994, 10, 121-130.